Axon Enterprise
AXON
$281.67
Share price
-0.02%
Change (1 day)
46.60%
Change (1 year)
P/S ratio for Axon Enterprise (AXON)
P/S ratio as of June 2024 (TTM): 12.8
According to Axon Enterprise 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.7632. At the end of 2023 the company had a P/S ratio of 12.4.
P/S ratio history for Axon Enterprise from 2002 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 12.4 | 24.77% |
| 2022 | 9.92 | -20.29% |
| 2021 | 12.5 | 8.52% |
| 2020 | 11.5 | 39.69% |
| 2019 | 8.21 | 34.09% |
| 2018 | 6.13 | 50.18% |
| 2017 | 4.08 | -13.67% |
| 2016 | 4.72 | 0.71% |
| 2015 | 4.69 | -45.01% |
| 2014 | 8.53 | 40.43% |
| 2013 | 6.07 | 47.76% |
| 2012 | 4.11 | 30.06% |
| 2011 | 3.16 | -6.64% |
| 2010 | 3.39 | 29.73% |
| 2009 | 2.61 | -25.63% |
| 2008 | 3.51 | -60.99% |
| 2007 | 9.00 | 29.86% |
| 2006 | 6.93 | -23.36% |
| 2005 | 9.04 | -68.33% |
| 2004 | 28.5 | 100.56% |
| 2003 | 14.2 | 1129.62% |
| 2002 | 1.16 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 XBiotech XBIT | N/A | N/A | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | 6.39 | -49.91% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Exelixis EXEL | 3.28 | -74.32% | 🇺🇸 USA |